Adalimumab for Crohn's disease: long-term sustained benefit in a population-based cohort of 438 patients (Q87222587)

From Wikidata
Jump to navigation Jump to search
scientific article published on 31 January 2014
edit
Language Label Description Also known as
English
Adalimumab for Crohn's disease: long-term sustained benefit in a population-based cohort of 438 patients
scientific article published on 31 January 2014

    Statements

    Adalimumab for Crohn's disease: long-term sustained benefit in a population-based cohort of 438 patients (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit